FDA Final Postmarket Surveillance Guidance

The US FDA issued a final guidance entitled: “Postmarket Surveillance Under Section 522 of the Federal Food, Drug, and Cosmetic Act” dated May 16, 2016. The full guidance is at the link provided. .This includes special provisions for devices used on pediatric populations.

Corporate Office

15148 Springview St
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN) and Italy.